Hyperkalemia-induced ECG abnormalities in patients with reduced renal function
- PMID: 15630907
- DOI: 10.5414/cnp62465
Hyperkalemia-induced ECG abnormalities in patients with reduced renal function
Abstract
Hyperkalemia is a potentially lethal condition to be aware of in the presence of ECG abnormalities especially in patients with reduced renal function. However, ECG abnormalities are not always dependent on the degree ofhyperkalemia but may be aggravated by the rapidity of the development of hyperkalemia and by associated electrolyte disorders. We describe 3 patients with renal failure and different ECG changes induced by hyperkalemia. More severe changes were observed when hyperkalemia developed rapidly, but not in presence of electrolyte disorders. Even minor ECG abnormalities must alarm physicians in patients with renal failure since severe hyperkalemia is not always associated with critical ECG changes.
Similar articles
-
[Malignant arrhythmias caused by hyperkalemia: a new area of drug-induced electrolyte abnormalities].Orv Hetil. 2002 Mar 31;143(13):663-6. Orv Hetil. 2002. PMID: 11975043 Hungarian.
-
Chronic renal insufficiency.Pediatr Clin North Am. 1976 Nov;23(4):829-42. doi: 10.1016/s0031-3955(16)33364-8. Pediatr Clin North Am. 1976. PMID: 792783 Review. No abstract available.
-
ECG manifestations of multiple electrolyte imbalance: peaked T wave to P wave ("tee-pee sign").Ann Noninvasive Electrocardiol. 2009 Apr;14(2):211-4. doi: 10.1111/j.1542-474X.2009.00283.x. Ann Noninvasive Electrocardiol. 2009. PMID: 19419407 Free PMC article.
-
ECG case studies. Hyperkalemia.Crit Care Nurse. 1992 Mar;12(3):55-9. Crit Care Nurse. 1992. PMID: 1559383 No abstract available.
-
[Water-electrolyte and acid-base disorders. III. Hyperkalemia].Bol Med Hosp Infant Mex. 1988 Sep;45(9):619-25. Bol Med Hosp Infant Mex. 1988. PMID: 3056438 Review. Spanish. No abstract available.
Cited by
-
Maintained renin-angiotensin-aldosterone system inhibitor therapy with sodium zirconium cyclosilicate following a hyperkalaemia episode: a multicountry cohort study.Clin Kidney J. 2024 Mar 25;17(5):sfae083. doi: 10.1093/ckj/sfae083. eCollection 2024 May. Clin Kidney J. 2024. PMID: 38699484 Free PMC article.
-
A cost-effectiveness analysis of patiromer in the UK: evaluation of hyperkalaemia treatment and lifelong RAASi maintenance in chronic kidney disease patients with and without heart failure.BMC Nephrol. 2023 Mar 9;24(1):47. doi: 10.1186/s12882-023-03088-3. BMC Nephrol. 2023. PMID: 36890464 Free PMC article.
-
The frequency of hyperkalemia and its significance in chronic kidney disease.Arch Intern Med. 2009 Jun 22;169(12):1156-62. doi: 10.1001/archinternmed.2009.132. Arch Intern Med. 2009. PMID: 19546417 Free PMC article.
-
Hyperkalemic recurrent bilateral lower extremity weakness in a patient on hemodialysis.Case Rep Emerg Med. 2012;2012:243501. doi: 10.1155/2012/243501. Epub 2012 May 13. Case Rep Emerg Med. 2012. PMID: 23326707 Free PMC article.
-
Duration of sodium zirconium cyclosilicate treatment and continuation of RAASi therapy after a hyperkalaemia episode.ESC Heart Fail. 2025 Jun;12(3):1776-1785. doi: 10.1002/ehf2.15171. Epub 2024 Dec 10. ESC Heart Fail. 2025. PMID: 39659133 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Medical